Medication Management of Parkinson's Disease: Early versus Advanced Stages

Pharmacology, Toxicology and Pharmaceutical Science

• Amantadine 33%
• Amine Oxidase (Flavin Containing) 50%
• Antiparkinson Agent 33%
• Bradykinesia 16%
• Catechol 33%
• Cholinergic Receptor Blocking Agent 33%
• Comorbidity 16%
• Degenerative Disease 16%
• Disease Exacerbation 16%
• Dopamine Receptor Stimulating Agent 50%
• Dyskinesia 33%
• Extrapyramidal Symptoms 16%
• Levodopa 50%
• Methyltransferase 16%
• Methyltransferase Inhibitor 16%
• Neuroprotective Agent 16%
• Parkinson's Disease 100%
• Pergolide 16%
• Pramipexole 50%
• Replacement Therapy 16%
• Ropinirole 33%
• Selegiline 33%
• Symptom 16%